Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ovarian Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ovarian Cancer
    TopAbstracts in Ovarian Cancer 10/21/2009 - (DGNews)
    Neoadjuvant Chemotherapy Confers Important Benefits in Advanced Ovarian Cancer: Presented at ACS - (DGDispatch)
    Dose-Dense Chemotherapy Improves Survival in Advanced Ovarian Cancer - (DGNews)
    TopAbstracts in Ovarian Cancer 09/23/2009 - (DGNews)
    FDA Approves Test to Help Detect Ovarian Cancer - (DGNews)

    News archive

     Recent webcasts/CME - Ovarian Cancer
  • Current Therapeutic Options and Clinical Issues in Recurrent Ovarian Cancer: Where Do We Stand?
  • Ovarian Cancer: Designed for the Primary Care Physician

    Webcasts/CME archive

     Recent cases - Ovarian Cancer
      Leser-Trelat Sign Presenting in a Patient with Ovarian Cancer: A Case Report
      Large Family with Both Parents Affected by Distinct BRCA1 Mutations: Implications for Genetic Testing
      Primary Hepatic Embryonal Sarcoma Masquerading as Metastatic Ovarian Cancer
      Choroidal Eye Metastases from (Recurrent) Primary Peritoneal Carcinoma: Case Report and Review of the Literature
      A Case of Meigs Syndrome Mimicking Metastatic Breast Carcinoma

      Cases archive
        




      my personal edition > ovarian cancer > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Increased Dietary Flavonoids May Reduce Ovarian Cancer Risk: Presented at AACR

      By Rabiya S. Tuma, PhD

      WASHINGTON, D.C. -- April 10, 2006 -- Women with the highest intake of dietary flavonoids may be at reduced risk of ovarian cancer, according to a prospective analysis from the Nurses' Health Study.

      Margaret A. Gates, a doctoral student at the Harvard School of Public Health, Boston, Massachusetts, United States, reported the results here on April 4th at the 97th Annual Meeting of the American Association for Cancer Research (AACR).

      The researchers analyzed food frequency questionnaires from 66,384 participants in the Nurses' Health Study and evaluated the association between flavonoid intake and ovarian cancer risk. Between 1984 and 2002, there were 344 ovarian cancer cases diagnosed in the population.

      Overall there was no relationship between ovarian cancer risk and flavonoids intake. However, when the team compared women in the highest and lowest quintiles for total flavonoid intake they found a significant inverse trend toward decreased ovarian cancer risk with increased intake of flavonoids (P for trend =.04). The relative risk was not significantly different for the two groups (RR=0.78, 95% CI, 0.53-1.13).

      Individual flavonoids showed different associations with risk, Ms. Gates said. For example, there was a significant risk reduction detected between the highest and lowest quintiles of kaempferol intake (RR =.66, 95% CI, 0.43-0.89, P for trend =.002). By contrast, the data suggested that myricetin (RR =.74, 95% CI, 0.51-1.06, P for trend =.01) and quercetin (RR=0.83, 95% CI, 0.57-1.21, P for trend =.06) may have a protective effect but did not reach statistical significance.

      The estimate of flavonoid intake was based on a 126-item food questionnaire that was administered at enrollment in 1984, as well as in 1990, 1994, and 1998.

      Flavonoids, occur naturally in plants and protect them from oxidative damage. Flavonoids are abundant in tea, red wine, soybeans, fruits and vegetables.

      "In the Nurses' Health Study population, the primary contributors to kaempferol intake, for which we saw the strongest association, were tea, broccoli and kale," said Ms. Gates. "Some other common foods that contain kaempferol include brussel sprouts, strawberries, grape fruit, and various types of greens." For myricetin, commonly consumed foods in the study population included tea, beans, raisins and walnuts.

      Currently there is no recommended dietary intake levels for flavonoids, commented Brian N. Fink, MPH, doctoral candidate at the University of North Carolina at Chapel Hill, who has been studying the impact of dietary flavonoids on breast cancer.


      [Presentation title: A Prospective Analysis of Dietary Flavonoid Intake and Epithelial Ovarian Cancer Incidence. Abstract 4013]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send